Arcadia Biosciences (RKDA) Stock Statistics & Valuation Metrics

Arcadia Biosciences has a market cap or net worth of $6.77M. The enterprise value is $1.22M.

Arcadia Biosciences has 1,367,040 shares outstanding. The number of shares has decreased by -2.65% in one year.

Arcadia Biosciences’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -32.90%.

The current PE Ratio of Arcadia Biosciences is -1.15. Arcadia Biosciences’s PEG ratio is -0.03.

In the last 12 months, Arcadia Biosciences had revenue of 5.04M and earned -7.04M in profits. Earnings per share was -5.16.

In the last 12 months, operating cash flow was -9.63M and capital expenditures -16.00K, giving a free cash flow of -9.64M billion.

Arcadia Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Arcadia Biosciences upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.

Arcadia Biosciences as a current ratio of 3.61, with Debt / Equity ratio of 2.49%

In the past 12 months, Arcadia Biosciences has paid 8.00K in taxes.

Arcadia Biosciences EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.41.

Arcadia Biosciences has $4.24M in cash and marketable securities with $155.00K in debt, giving a net cash position of -$4.09M billion.

Gross margin is 37.67%, with operating margin of -72.31%, and net profit margin of -139.50%.

The average price target for Arcadia Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy